Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on AFM24 dose optimization ...
Nordot on MSN17h
Mannheim knife attacker admits guilt, expresses remorseA 26-year-old man on trial for the murder of a police officer and injury to five others on the market square of the German ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback